Streamed video of CEO Martin Vidaeus presenting at Aktieportföljen Live in Stockholm, Sweden on Oct. 11, 2022
14 oktober, 2022
14 oktober, 2022
Get an update of the development activities surrounding Redwood Pharma’s two products for the treatment of dry eye disease, its near-term plans for seeking RP501 regulatory approval, scaling up of production, commercialization and launch. More information about the coming rights issue in November is also provided by CEO Martin Vidaeus.
To view the presentation and a question and answer session, please see the following link:
https://youtu.be/oO_Ytq3idwQ
14 oktober, 2022
Get an update of the development activities surrounding Redwood Pharma’s two products for the treatment of dry eye disease, its near-term plans for seeking RP501 regulatory approval, scaling up of production, commercialization and launch. More information about the coming rights issue in November is also provided by CEO Martin Vidaeus.
To view the presentation and a question and answer session, please see the following link:
https://youtu.be/oO_Ytq3idwQ
Analyser

Aktieråd


SBB

Inflationen
Analyser

Aktieråd


SBB

Inflationen
1 DAG %
Senast

Stockholmsbörsen
12 december, 17:47
Börsen föll tillbaka – stänger veckan rött
Castellum
12 december, 17:27
Castellums VD shoppar loss
Nordea Bank
12 december, 17:02
Storbankerna är dyrare än vanligt – vi slopar köpråden
blankning
12 december, 16:41
Här är de mest blankade aktierna just nu
Coffee Stain Group B
12 december, 14:25
Analys: Uppsidan lockar i Embracers avknoppning
OMX Stockholm 30
1 DAG %
Senast
2 821,01